Earnings and COVID-19 developments were in focus - Monday Review, January 25

Earnings and COVID-19 developments were in focus - Monday Review, January 25

Some markets have chosen to focus on the positive, eyeing corporate earnings and the upcoming US stimulus package

The US

The tech sector moved most stocks on Monday, ahead of market-moving earnings from tech giants. USA30 fell 0.12%, while USA500 was up 0.38%. TECH100 gained 0.69%, closing at a record high.

Crude oil rose 0.75% closing the session at $52.66 per barrel.

The Dollar Index slipped 0.11% to 90.110.

Asia and Australia

The stock market was up on Monday as it focused on the US stimulus package's prospects, putting aside the issues with the COVID-19 vaccine rollout.

Japan225 closed up 0.67%. hitting a five-year high.

HongKong45 rose 1.43% after the city's lockdown was lifted as the COVID-19 testing program concluded.

Down under, Australia200 was up 0.41%.

USD/JPY traded at 103.76 after it lost 0.05%.

Europe

The benchmarks traded mixedly, as investors kept an eye on the COVID-19 vaccine developments. Moreover, some European countries are considering even a third lockdown to curb the number of infections. Europe50 was up 0.3%. France40 lost 0.1%, while Germany30 traded 1.66% lower.

Brent oil gained 0.64% reaching $55.77 per barrel.

EUR/USD was at 1.2167.

Sources: reuters.com, investing.com

This information prepared by za.capex.com is not an offer or a solicitation for the purpose of purchase or sale of any financial products referred to herein or to enter into any legal relations, nor an advice or a recommendation with respect to such financial products.

This information is prepared for general circulation. It does not regard to the specific investment objectives, financial situation or the particular needs of any recipient.

You should independently evaluate each financial product and consider the suitability of such a financial product, by taking into account your specific investment objectives, financial situation or particular needs, and by consulting an independent financial adviser as needed, before dealing in any financial products mentioned in this document.

This information may not be published, circulated, reproduced or distributed in whole or in part to any other person without the Company’s prior written consent. Past performance is not always indicative of likely or future performance. Any views or opinions presented are solely those of the author and do not necessarily represent those of za.capex.com

JME Financial Services (Pty) Ltd trading as ZA.CAPEX.COM acts as intermediary between the investor and Magnasale Trading Ltd, the counterparty to the contract for difference purchased by the Investor via ZA.CAPEX.COM, authorised & regulated by the Cyprus Securities and Exchange Commission with license number 264/15. Magnasale Trading Ltd is the principal to the CFD purchased by investors.